Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

iPS Cell Differentiation01:22

iPS Cell Differentiation

2.9K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.9K
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

4.3K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.3K
Gene Therapy00:59

Gene Therapy

26.1K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
26.1K
Tumor Immunotherapy01:27

Tumor Immunotherapy

736
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
736

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Super-robust and sustainable bamboo structural material enabled by bonding network reconstruction.

Nature communications·2026
Same author

Unveiling the regulation of biochar and ferrihydrite on organic carbon stabilization, CH<sub>4</sub> emission and microbial community in paddy soil.

Journal of environmental sciences (China)·2026
Same author

Traditional Chinese medicine in acne treatment: From classical formulas to bioactive phytoconstituents and mechanisms.

Journal of ethnopharmacology·2026
Same author

Conservation-Oriented Analysis of <i>Apocynum venetum</i>'s Distribution in Response to Climate Change Based on MaxEnt Model.

Plants (Basel, Switzerland)·2026
Same author

Effectiveness of whole grain to body weight and cardiometabolic risk in adults with obesity: a parallel randomised controlled trial.

Frontiers in nutrition·2026
Same author

Unveil Multi-Picture Descriptions for Multilingual Mild Cognitive Impairment Detection via Contrastive Learning.

... IEEE Global Communications Conference. IEEE Global Communications Conference·2026

Related Experiment Video

Updated: Oct 15, 2025

Enhancing Chimeric Antigen Receptor-Extracellular Vesicles (CAR-EV) Technology: The Future of Cancer Therapy
07:33

Enhancing Chimeric Antigen Receptor-Extracellular Vesicles (CAR-EV) Technology: The Future of Cancer Therapy

Published on: September 19, 2025

249

Advances in Universal CAR-T Cell Therapy.

Haolong Lin1, Jiali Cheng1, Wei Mu1

  • 1Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Frontiers in Immunology
|October 25, 2021
PubMed
Summary

Universal CAR-T (UCAR-T) cell therapy offers a promising solution to overcome limitations of traditional CAR-T treatments. This review explores UCAR-T advancements, safety, and future prospects in cancer therapy.

Keywords:
CRISPR/Cas9cellular immunotherapychimeric antigen receptor T cell therapygene editinguniversal chimeric antigen receptor T cell therapy

More Related Videos

Author Spotlight: Advancements in CAR-T Cell Manufacturing and Gene Therapy Production
06:18

Author Spotlight: Advancements in CAR-T Cell Manufacturing and Gene Therapy Production

Published on: August 18, 2023

3.0K
Clinical Application of Sleeping Beauty and Artificial Antigen Presenting Cells to Genetically Modify T Cells from Peripheral and Umbilical Cord Blood
09:29

Clinical Application of Sleeping Beauty and Artificial Antigen Presenting Cells to Genetically Modify T Cells from Peripheral and Umbilical Cord Blood

Published on: February 1, 2013

18.6K

Related Experiment Videos

Last Updated: Oct 15, 2025

Enhancing Chimeric Antigen Receptor-Extracellular Vesicles (CAR-EV) Technology: The Future of Cancer Therapy
07:33

Enhancing Chimeric Antigen Receptor-Extracellular Vesicles (CAR-EV) Technology: The Future of Cancer Therapy

Published on: September 19, 2025

249
Author Spotlight: Advancements in CAR-T Cell Manufacturing and Gene Therapy Production
06:18

Author Spotlight: Advancements in CAR-T Cell Manufacturing and Gene Therapy Production

Published on: August 18, 2023

3.0K
Clinical Application of Sleeping Beauty and Artificial Antigen Presenting Cells to Genetically Modify T Cells from Peripheral and Umbilical Cord Blood
09:29

Clinical Application of Sleeping Beauty and Artificial Antigen Presenting Cells to Genetically Modify T Cells from Peripheral and Umbilical Cord Blood

Published on: February 1, 2013

18.6K

Area of Science:

  • Immunology
  • Oncology
  • Biotechnology

Background:

  • Chimeric antigen receptor T (CAR-T) cell therapy shows significant success in treating hematological malignancies.
  • Autologous CAR-T therapy faces challenges including high costs, long production times, and limited cell availability.

Purpose of the Study:

  • To review the progress and challenges of CAR-T cell therapy.
  • To compare universal CAR-T (UCAR-T) cell therapy with traditional CAR-T therapy.
  • To summarize safety, efficiency, and future prospects of UCAR-T therapy.

Main Methods:

  • Literature review and comprehensive comparison of CAR-T and UCAR-T cell therapies.
  • Analysis of safety and efficiency data for UCAR-T therapy.
  • Exploration of alternative immune cells for CAR-T therapy.

Main Results:

  • UCAR-T cell therapy presents a potential solution to the limitations of autologous CAR-T therapy.
  • The review details advancements, safety considerations, and efficiency of UCAR-T approaches.
  • Other immune cells are identified as potential complements to UCAR-T cells.

Conclusions:

  • UCAR-T cell therapy is a significant advancement with the potential to broaden CAR-T accessibility.
  • Further research into safety, efficiency, and complementary cell types is crucial for optimizing UCAR-T therapy.
  • UCAR-T therapy holds promise for the future landscape of cancer treatment.